2023
Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes
Criego A, Carlson A, Brown S, Forlenza G, Bode B, Levy C, Hansen D, Hirsch I, Bergenstal R, Sherr J, Mehta S, Laffel L, Shah V, Bhargava A, Weinstock R, MacLeish S, DeSalvo D, Jones T, Aleppo G, Buckingham B, Ly T, Group F. Two Years with a Tubeless Automated Insulin Delivery System: A Single-Arm Multicenter Trial in Children, Adolescents, and Adults with Type 1 Diabetes. Diabetes Technology & Therapeutics 2023, 26: 11-23. PMID: 37850941, PMCID: PMC10794844, DOI: 10.1089/dia.2023.0364.Peer-Reviewed Original ResearchConceptsAdolescents/adultsPivotal trialsInsulin delivery systemsSingle-arm multicenter trialYears of useClinical trial registrationType 1 diabetesLong-term safetyMonths of useLong-term useDiabetic ketoacidosisMulticenter trialSevere hypoglycemiaTRIAL REGISTRATIONGlycemic outcomesType 1Delivery systemExtension phaseMonthsTrialsTarget rangeAdultsHbA1cChildrenEpisodes
2022
P077Pilot study on a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant
Clure C, Sheeder J, Lazorwitz A. P077Pilot study on a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant. Contraception 2022, 116: 91. DOI: 10.1016/j.contraception.2022.09.101.Peer-Reviewed Original ResearchEtonogestrel contraceptive implantContraceptive implantsENG implantENG levelsSide effectsMedian pain scoreTime pointsReproductive-aged womenScapular insertionPain scoresSite painMedian ageMedian BMIImplant useInferior edgeInsertion siteWeek twoYears of useFirst weekPilot studyImplant usersPharmacokineticsImplantsFirst yearWeeks
2020
The Development and Implementation of a Novel Electronic Consult System by a Laboratory Medicine Service: Experience From the First 2 Years of Use
Stendahl K, Siddon AJ, Peaper DR, Hauser RG, Campbell S, Tormey CA. The Development and Implementation of a Novel Electronic Consult System by a Laboratory Medicine Service: Experience From the First 2 Years of Use. Archives Of Pathology & Laboratory Medicine 2020, 145: 75-81. PMID: 33367659, DOI: 10.5858/arpa.2019-0267-oa.Peer-Reviewed Original ResearchConceptsE-consultsMedicine serviceLaboratory medicine servicesConsult systemPeripheral blood smear reviewE-consult implementationMajority of consultsType of consultBlood smear reviewHematology/oncologyMedian turnaround timeHealth care facilitiesPrimary careMedical recordsProvider communicationClinical impactResident reviewCare facilitiesSmear reviewTest utilizationPathologist reviewYears of useBlood bankConsultsUtilization trends
1996
Black Americans have an increased rate of angiotensin converting enzyme inhibitor‐associated angioedema
Brown N, Ray W, Snowden M, Griffin M. Black Americans have an increased rate of angiotensin converting enzyme inhibitor‐associated angioedema. Clinical Pharmacology & Therapeutics 1996, 60: 8-13. PMID: 8689816, DOI: 10.1016/s0009-9236(96)90161-7.Peer-Reviewed Original ResearchConceptsACE inhibitor useEnzyme (ACE) inhibitor-associated angioedemaInhibitor useACE inhibitorsRelative riskWhite subjectsACE inhibitor-associated angioedemaACE inhibitor doseRate of angiotensinRetrospective cohort studyRisk of angioedemaTennessee Medicaid programAssociation of racePotential confounding factorsEffect of doseSpecific ACE inhibitorDiuretic useCohort studyConcurrent medicationsPatient characteristicsPrevious hospitalizationAngioedemaInhibitor doseConfounding factorsYears of use
1994
Pneumococcal Vaccine After 15 Years of Use: Another View
Fedson D, Shapiro E, LaForce F, Mufson M, Musher D, Spika J, Breiman R, Broome C. Pneumococcal Vaccine After 15 Years of Use: Another View. JAMA Internal Medicine 1994, 154: 2531-2535. DOI: 10.1001/archinte.1994.00420220021003.Commentaries, Editorials and LettersPneumococcal vaccineYears of useInfectious Diseases SocietyWorld Health Organization Regional OfficeAdvisory CommitteePneumococcal vaccinationDiseases SocietyVaccine effectivenessRetrospective studyVaccine trialsClinical effectivenessAmerican CollegeElderly populationOngoing critical reviewVaccineAvailable evidenceNational Advisory CommitteeTechnical Advisory GroupImmunizationAdvisory GroupTask ForceUnited StatesConclusive evidenceGroupEvidence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply